Pharmacokinetics (PK) of posaconazole in subjects with varying degrees of renal insufficiency.

被引：0
|
作者：
Courtney, R [1 ]
Sansone, A [1 ]
Statkevich, P [1 ]
Martinho, M [1 ]
Richards, W [1 ]
Laughlin, M [1 ]
机构：
[1] Schering Plough Corp, Res Inst, Kenilworth, NJ 07033 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2003年 / 73卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P45 / P45
页数：1
相关论文
共 50 条
  • [1] Posaconazole pharmacokinetics, safety, and tolerability in subjects with varying degrees of chronic renal disease
    Courtney, R
    Sansone, A
    Smith, W
    Marbury, T
    Statkevich, R
    Martinho, M
    Laughlin, M
    Swan, S
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (02): : 185 - 192
  • [2] Single dose pharmacokinetics (PK) of peg-interferon alfa-2b (P) in subjects with various degrees of chronic renal insufficiency.
    Marbury, T
    Lambrecht, K
    Lambrecht, L
    Pittenger, A
    Swan, S
    Sack, M
    Clarke, L
    Glue, P
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (02) : P92 - P92
  • [3] Pharmacokinetics (PK) of hydroxypropylβcyclodextrin (HPC) in subjects with varying degrees of renal function.
    Plaisance, K
    Burstein, A
    Zhou, H
    Lee, P
    Hassell, A
    Wu, J
    Travers, S
    Young, D
    Pesco-Koplowitz, L
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (02) : 237 - 237
  • [4] Pharmacokinetics of ezetimibe in subjects with normal renal function or severe chronic renal insufficiency.
    Reyderman, L
    Kosoglou, T
    Statkevich, P
    Pember, L
    Maxwell, S
    Batra, V
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (02) : P27 - P27
  • [5] Pharmacokinetics of rosiglitazone in patients with varying degrees of renal insufficiency
    Chapelsky, MC
    Thompson-Culkin, K
    Miller, AK
    Sack, M
    Blum, R
    Freed, MI
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 43 (03): : 252 - 259
  • [6] Bucindolol (B) single dose pharmacokinetics (PK) in subjects with varying degrees of renal impairment.
    Ogunremi, A
    Swan, S
    Gehr, T
    Sica, D
    Sellers, J
    Roberge, P
    Ward, D
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (02) : 158 - 158
  • [7] An open label study of the pharmacokinetics of intravenous (IV) cidofovir in subjects with varying degrees of renal insufficiency
    Brody, SR
    Humphreys, M
    Gambertoglio, JG
    Stagg, R
    Cundy, K
    Aweeka, FT
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 61 (02) : PI49 - PI49
  • [8] Pharmacokinetics (PK) of palifermin in subjects with different degrees of renal impairment
    Gillespie, B
    Zia-Amirhosseini, P
    Salfi, M
    Wang, J
    Robson, R
    Sullivan, JT
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (09): : 1071 - 1071
  • [9] Pharmacokinetics of pilocarpine in subjects with varying degrees of renal function
    St Peter, JV
    Lambrecht, LJ
    Gunderson, BW
    Andersen, SA
    Gallagher, SC
    Swan, SK
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 40 (12): : 1470 - 1475
  • [10] Pharmacokinetics of Tapentadol in Subjects With Varying Degrees of Renal Impairment
    Smit, J. W.
    Kleideiter, E.
    Brett, M.
    Lannie, C.
    Mangold, B.
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (09): : 1079 - 1079
12345